Estimation of antigenic tetanus toxoid extracted from biodegradable microspheres

Biologicals

Volumn 24, Issue 1, 1996, Pages 57-65

  Xing, Dorothy K L ^a   McLellan, Kay ^a   Corbel, Michael J ^a   Sesardic, Dorothea ^a  

^a NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MICROSPHERE; MONOCLONAL ANTIBODY; TETANUS TOXOID;

ACCURACY; ANIMAL EXPERIMENT; ANTIGENICITY; ARTICLE; DRUG DETERMINATION; EXTRACTION; FEMALE; GUINEA PIG; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALIA; CAVIA PORCELLUS; SUS SCROFA;

EID: 0029929593     PISSN: 10451056     EISSN: None     Source Type: Journal    
DOI: 10.1006/biol.1996.0006     Document Type: Article

References (18)

1. Wise DL,Trantolo DJ, Marino RT, Kitchell JP. Opportunities and challenges in the design of implantable biodegradable polymeric systems for the delivery of antimicrobial agents and vaccines. Adv Drug Deliv Rev 1987; 1: 19-39.
2. Miller RA, Brady JM, Cutright DE. Degradation rates of oral resorbable implants (polylactates and polyglycolates): Rate modification with changes in PLA/PGA copolymer ratios. J Biomed Mater Res 1977; 2: 711-719.
3. Sanders LM, Kent JS, McRae GI, Vickery BH, Tice TR, Lewis DH. Controlled release of a luteinizing hormone-releasing hormone analogue from poly(d,l-lactide-co-glycolide) microspheres. J Pharm Sci 1984; 73: 1294-1297.
4. Melville-Smith ME. Single radial immunodiffusion as a method for the identification and quantification of diphtheria and tetanus toxoid in absorbed vaccines. J Biological Standard 1985; 13: 77-86.
5. Almeida AJ, Alpar HO, Brown MRW. Immune response to nasal delivery of antigenically intact tetanus toxoid associated with poly (L-lactic acid) microspheres in rats, rabbits and guinea pigs. J Pharm Pharmacol 1993; 45: 198-203.
6. Eldridge JH, Staas JK, Meulbroek JA, McGhee JR, Tice TR, Gilley RM. Biodegradable microspheres as a vaccine delivery system. Mol Immunol 1991; 28: 287-294.
7. Hora MS, Rana RK, Nunberg JH, Tice TR, Gilley RM, Hudson ME. Release of human serum albumin from poly(lactide-co-glycolide) microspheres. Pharm Res 1990; 7: 1190-1194.
8. Alonso MJ, Gupta RK, Min C, Siber GR, Langer R. Biodegradable microspheres as controlled release tetanus toxoid delivery systems. Vaccine 1994; 12: 299-306.
9. Hazrati AM, Atkins TJ, Stohere RC, Meyer L. In vivo studies of controlled release tetanus vaccine. Proceed Inter Symp Control Rel Bioact Mater 1992; 19: 114-115.
10. Kersten G. Evaluation of controlled release tetanus toxoid vaccines. WHO 1992-1993 report.
11. Men Y, Thomasin C, Merkle HP, Gander B, Corradin G. A single administration of tetanus toxoid in biodegradable microspheres elicit T cell and antibody responses similar or superior to those obtained with aluminium hydroxide. Vaccine 1995; 13: 683-689.
12. Gupta RK, Siber GR, Alonso MJ, Langer R. Development of a single-dose tetanus toxoid based on controlled release from biodegradable and biocompatible polyester microspheres. In: Brown F, Chanock R, Ginsberg H and Lerner R, eds. Vaccine 93, Cold Spring Harbour Laboratory Press, Cold Spring Harbour, 1993; 391-396.
13. Laemmli UK. Cleavage of structural proteins during the assembly of the head of the bacteriophage T4. Nature (London) 1970; 227: 680-685.
14. Sheppard AJ, Cussell D, Hughes M. Production and characterization of monoclonal antibodies to tetanus toxin. Infect Immunity 1984; 43: 710-714.
15. Redhead K, Sesardic D, Yost SE, Attwell AM, Watkins J, Hoy CS, Plumb E, Corbel MJ. Interaction of Haemophilus influenzae type b conjugate vaccines with diphtheria-tetanus-pertussis vaccine in control tests. Vaccine 1994; 12: 1460-1466.
16. British Pharmacopoeia, 1993 Appendix XIV pp 1184.
17. Esparza I, Kissel T. Parameters affecting the immunogenicity of microencapsulated tetanus toxoid. Vaccine 1992; 10: 714-720.
18. Heyningen SV. Binding of ganglioside by the chains of tetanus toxin. FEBS Lett 1976; 68: 5-7.